24 Anticoagulants Flashcards
In what form are coagulation factors present in blood?
- Inactive zygomens
- Serine proteases
- Cofactors
- Calcium- important cofactor
Where are heparins produced naturally in the body?
- Mast cells
- Vascular endothelium
How do we acquire heparins for pharmaceutical use?
- Porcine intestinal mucosa
- Bovine lung
How do heparins work? (general terms?
Enhance antithrombin III activity
Unfractionated heparin has an unpredictable elimination. What is its half life like at high doses? What is its elimination like at low doses?
Low doses: half-life= 30 mins
High doses: half life= 2hrs
What is the mechanism of action for unfractionated heparin?
Binds to antithrombin III (ATIII)
Conformational change and increased activity of ATIII
- Heparin binds ATIII and thrombin (IIa)
- Catalyses inhibition of IIa
- ATIII binds to Xa and inhibits it
Give 2 examples of low molecular weight heparins.
- Dalteparin
- Enoxaparin
How are low molecular weight heparins normally administered?
Sub cutaneous
(Enoxaparin i.v. in ACS)
What is the bioavailabilty of LMWHs like? What are their half-lives like?
- Bioavailability= 90%
- Half life= 2+hrs
Why do low molecular weight heparins have a more predictable dose response than Unfractionated heparin?
- Absorbed more uniformly
- Do not bind to endothelial cells, plasma proteins, macrophages
Outline the mechanism of action for low molecular weight heparins.
Enhance ATIII activity - inhibit factor Xa specifically
Fondaparinux is a synthetic pentasaccharide.
- How does it work?
- How is it administered?
- What is it’s half life?
- How does it work?
- Like LMWH
- Binds to ATIII
- Selectively inhibits Xa
- How is it administered?
- S.C
- What is it’s half life?
- 18hrs
How do we monitor Unfractionated Heparin?
aPTT (activated partial thromboplastin time)
Dose titrated against this value
When might UFH be used instead of LMWH?
UFH=
- severe renal impairment
- fine control
What are the indications for heparins? (3)
- Venous thromboembolism
- Prevention
- Perioperative prophylaxis
- DVT and PE
- Initally and long term in some patients
- Cancer related VTE
- Prevention
- Pregnancy (doesn’t cross placenta)
- Monitored with caution
- ACS
- Reduce recurrence/extension of coronary artery thrombosis
- STEMI
- NSTEMI
- Reduce recurrence/extension of coronary artery thrombosis